Although the mechanism by which capecitabine interferes with the expression of CTLA-4 in CRC tissues and cells is still unknown, this evidence is sufficient to reflect the critical role of CTLA-4 in the development of CRC. This evidence concerns the gene CTLA4 and colorectal carcinoma.